tbuckley/cabot-search huggingface dataset:
Exposure to Household Air Pollution from Wood Combustion and Association with Respiratory Symptoms and Lung Function in Nonsmoking Women: Results from the RESPIRE Trial, Guatemala
Authors: Daniel Pope, Esperanza Diaz, Tone Smith-Sivertsen, Rolv T. Lie, Per Bakke, John R. Balmes, Kirk R. Smith, Nigel G. Bruce
Journal: Environmental Health Perspectives (2014)

BackgroundWith 40% of the world's population relying on solid fuel, household air pollution (HAP) represents a major preventable risk factor for COPD (chronic obstructive pulmonary disease). Meta-analyses have confirmed this relationship; however, constituent studies are observational, with virtually none measuring exposure directly.ObjectivesWe estimated associations between HAP exposure and respiratory symptoms and lung function in young, nonsmoking women in rural Guatemala, using measured carbon monoxide (CO) concentrations in exhaled breath and personal air to assess exposure.MethodsThe Randomized Exposure Study of Pollution Indoors and Respiratory Effects (RESPIRE) Guatemala study was a trial comparing respiratory outcomes among 504 women using improved chimney stoves versus traditional cookstoves. The present analysis included 456 women with data from postintervention surveys including interviews at 6, 12, and 18 months (respiratory symptoms) and spirometry and CO (ppm) in exhaled breath measurements. Personal CO was measured using passive diffusion tubes at variable times during the study. Associations between CO concentrations and respiratory health were estimated using random intercept regression models.Results:Respiratory symptoms (cough, phlegm, wheeze, or chest tightness) during the previous 6 months were positively associated with breath CO measured at the same time of symptom reporting and with average personal CO concentrations during the follow-up period. CO in exhaled breath at the same time as spirometry was associated with lower lung function [average reduction in FEV1 (forced expiratory volume in 1 sec) for a 10% increase in CO was 3.33 mL (95% CI: –0.86, –5.81)]. Lung function measures were not significantly associated with average postintervention personal CO concentrations.Conclusions:Our results provide further support for the effects of HAP exposures on airway inflammation. Further longitudinal research modeling continuous exposure to particulate matter against lung function will help us understand more fully the impact of HAP on COPD.Citation:Pope D, Diaz E, Smith-Sivertsen T, Lie RT, Bakke P, Balmes JR, Smith KR, Bruce NG. 2015. Exposure to household air pollution from wood combustion and association with respiratory symptoms and lung function in nonsmoking women: results from the RESPIRE Trial, Guatemala. Environ Health Perspect 123:285–292; http://dx.doi.org/10.1289/ehp.1408200
Safety and Efficacy of the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with WaldenstrC6m Macroglobulinemia from a Phase 2 Trial
Authors: Gang An, Daobin Zhou, Weili Zhao, Keshu Zhou, Jianyong Li, Jianfeng Zhou, Liping Xie, Jie Jin, Liye Zhong, Lingzhi Yan, Haiyi Guo, Chenmu Du, Jane Huang, William Novotny, Jinhua Zhong, Lugui Qiu
Journal: Blood (2020)
Making Clinical Decisions to Change Therapy Using Measurable Residual Disease Improves the Outcome in Multiple Myeloma
Authors: Joaquin Martinez Lopez, Rafael Alonso Fernández, Sandy W. Wong, Rafael Rios, Nina Shah, Maria Teresa Cedena Romero, Yanira Ruiz-Heredia, Jose M. Sanchez, Santiago Barrio Garcia, Thomas Martin, Jeffrey L. Wolf
Journal: Blood (2020)
Abstract IA04: Relating single cell function to tissue structure in human tumors using MIBI-TOF
Authors: R. Michael Angelo
Journal: Cancer Research (2020)

Abstract Understanding the role of distinct cellular phenotypes in tissue function, development, and pathogenesis requires tools that can rapidly and consistently quantify the expression of multiple proteins while preserving spatial information. To meet this need, we have developed Multiplexed Ion Beam Imaging by Time-Of-Flight (MIBI-TOF). MIBI-TOF uses secondary ion mass spectrometry to visualize up to 50 metal labeled antibodies at subcellular resolution simultaneously with histochemical stains and native biological elements. We have used this capability to study how single cell function and tissue structure interact at the tumor immune microenvironment, the human maternal-fetal interface, and in infectious disease. These studies have led us to develop scalable, automated, and extensible tools for image thresholding, single cell segmentation, cell clustering, and cell neighborhood analyses that can be deployed on any tissue. Through NIH HuBMAP and CIMAC initiatives, we are currently working to deploy this computational pipeline as well as preformulated antibody staining master mixes as a streamlined, end-to-end workflow for routine high dimensional tissue analysis in basic and translational research. Lastly, we are currently working to develop brighter primary ion sources and new metal reporter constructs that will permit full tissue section scanning while extending multiplexed detection to include RNA and DNA. Citation Format: R. Michael Angelo. Relating single cell function to tissue structure in human tumors using MIBI-TOF [abstract]. In: Proceedings of the AACR Virtual Special Conference on Tumor Heterogeneity: From Single Cells to Clinical Impact; 2020 Sep 17-18. Philadelphia (PA): AACR; Cancer Res 2020;80(21 Suppl):Abstract nr IA04.
Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia
Authors: Ibrahim Aldoss, Geoffrey L Uy, Norbert Vey, Ashkan Emadi, Peter H. Sayre, Roland B. Walter, Matthew C Foster, Martha L. Arellano, John E. Godwin, Matthew J. Wieduwilt, Michael T. Byrne, Laura C. Michaelis, Patrick J. Stiff, Matteo Giovanni Carrabba, Patrice Chevalier, Emmanuel Gyan, Christian Recher, Anjali S Advani, Martin Wermke, Harry P. Erba, Fabio Ciceri, Geert Huls, Mojca Jongen-Lavrencic, Max S. Topp, Antonio Curti, Farhad Ravandi, Michael P. Rettig, John Muth, Mary Beth Collins, Erin Timmeny, Kuo Guo, Jian Zhao, Kathy Tran, Patrick Kaminker, Priyanka Patel, Ouiam Bakkacha, Teia Curtis, Kenneth Jacobs, Maya Kostova, Jennifer Seiler, Bob Lowenberg, Sergio Rutella, Ezio Bonvini, Jan K Davidson-Moncada, John F. DiPersio
Journal: Blood (2020)
<i>High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation</i>
Authors: Genevieve Douglas, Michelle K Yong, Shio Yen Tio, Maggie Chau, Joe Sasadeusz, Monica Slavin, Mingdi Xie, David Ritchie, Lynette C.Y. Chee
Journal: Blood (2020)
Abstract MP120: Ryanodine Receptor 2 Prevents Endoplasmic Reticulum Stress-induced Defects in Cardiomyocyte Maturation
Authors: Yuxuan Guo, Blake Jardin, Silvia Guatimosim, William T Pu
Journal: Circulation Research (2020)

Cardiomyocyte (CM) maturation is an essential step in heart development that prepares the organ for robust and sustainable contractions. However, very little is known about the contribution of CM maturation to cardiac pathogenesis, partly due to the paucity of basic knowledge about maturation. For example, although calcium plays well-established roles in cardiac stress responses, whether normal calcium oscillations are required for CM maturation has not been examined. To address this question, we created mice with mosaic inactivation of ryanodine receptor 2 (RYR2), the central channel that mediates calcium release from sarcoplasmic/endoplasmic reticulum (SR/ER), in CMs. RYR2 was depleted in a small fraction of neonatal CMs by adeno-associated virus (AAV)-mediated Cas9-based somatic mutagenesis (CASAAV). The majority of CMs intentionally retained RYR2 expression, which circumvented cardiac dysfunction and death that would result from widespread calcium transient ablation. In RYR2-depleted CMs, sarcomere expansion, transverse-tubule formation, mitochondrial metabolism and maturational hypertrophy were impaired. Strikingly, these maturation defects were associated with unfolded protein response, with the activation of three major ER stress effectors: spliced Xbp1 (XBP1s), ATF6 N-terminus (ATF6N), and ATF4. Tauroursodeoxycholic acid, an ER stress-relieving drug, partially rescued the maturation defects in RYR2-depleted CMs. Over expression (OE) of XBP1s, ATF6N or ATF4 each impaired CM maturation, with phenotypic severity ranked as ATF4&gt;XBP1s&gt;ATF6N. ATF4 OE in neonatal CMs triggered both ultrastructural and transcriptomic changes highly correlated with RYR2 depletion phenotypes. Interestingly, ATF4 OE altered distinct transcriptomic programs in neonatal vs. adult CMs and caused ultrastructural defects only at the neonatal stage. No terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining was detected upon RYR2 depletion or ATF4 OE, excluding the contribution of apoptosis to maturation defects. Collectively, these data indicate that RYR2-mediated calcium handling prevents an adverse and stage-specific impact of ER stress on CM maturation, which lead to CM dysfunction.
Resource Utilization and Factors Prolonging Hospitalization for Patients with Relapsed and Refractory Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel
Authors: Agrima Mian, Wei Wei, Brian T. Hill, Betty K. Hamilton, Allison M. Winter, Jack Khouri, Brad Pohlman, Deepa Jagadeesh, Alex V. Mejia Garcia, Faiz Anwer, Aaron T. Gerds, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Navneet S. Majhail
Journal: Blood (2020)
Sotatercept (ACE-011) for Anemia of Myelofibrosis: A Phase 2 Study
Authors: Prithviraj Bose, Naveen Pemmaraju, Lucia Masarova, Sharon D. Bledsoe, Naval Daver, Elias Jabbour, Tapan M. Kadia, Zeev E. Estrov, Steven M. Kornblau, Michael Andreeff, Jorge E. Cortes, Nitin Jain, Gautam Borthakur, Yesid Alvarado, Julie Huynh-Lu, Madeleine Nguyen-Cao, Mary Ann Richie, Mackenzie H. Dobbins, Lingsha Zhou, Sherry A. Pierce, Xuemei Wang, Allison M. Pike, Guillermo Garcia-Manero, Hagop M. Kantarjian, Srdan Verstovsek
Journal: Blood (2020)
Clinical Implications of Minimal Residual Disease Detection in Infants with <i>KMT2A</i>-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
Authors: Janine Stutterheim, Inge M. van der Sluis, Paola De Lorenzo, Julia Alten, Philip Ancliff, Andishe Attarbaschi, Benoit Brethon, Andrea Biondi, Myriam Campbell, Giovanni Cazzaniga, Gabriele Escherich, Alina Ferster, Rishi Sury Kotecha, Birgitte Lausen, Chi Kong Li, Luca Lo Nigro, Franco Locatelli, Rolf Marschalek, Martin Schrappe, Jan Stary, Ajay Vora, Jan Zuna, Vincent H.J. Van Der Velden, Tomasz Szczepanski, Maria Grazia Valsecchi, Rob Pieters
Journal: Blood (2020)
Association of Changes in Missouri Firearm Laws With Adolescent and Young Adult Suicides by Firearms
Authors: Apurva Bhatt, Xi Wang, An-Lin Cheng, Kalee L. Morris, Luke Beyer, Abbie Chestnut, Kristy Steigerwalt, Jeffrey Metzner
Journal: JAMA Network Open (2020)

<h3>Importance</h3> Suicide by firearm is a major cause of mortality in young Missouri residents. Changes in statewide firearm policy may have contributed to changes in suicide rates. <h3>Objective</h3> To evaluate if changes in Missouri permit-to-purchase (PTP) and concealed carry firearm laws were associated with changes in rates of suicide by firearms in young Missouri residents. <h3>Design, Settings, and Participants</h3> This cross-sectional study examined rates of suicide by firearm in Missouri among adolescents (ages 14-18 years) and young adults (ages 19-24 years) from January 1999 to December 2018, following changes to state PTP and concealed carry law, in comparison with a donor state pool with existing firearm laws (13 states in PTP pool; 42 states in concealed carry pool) that did not make changes during this period. This study used a quasiexperimental, synthetic control design at the state level that defined Missouri as the treated state and treatment as changes in firearm laws. <h3>Exposures</h3> Legislative changes to Missouri's PTP and concealed carry firearm laws. <h3>Main Outcomes and Measures</h3> Age-adjusted annual rates of firearm-related suicide mortality per 100 000 people for adolescents (aged 14-18 years) and young adults (aged 19-24 years). <h3>Results</h3> Repeal of the PTP law was associated with a 21.8% increase in firearm suicide rates in young adults aged 19 to 24 years in Missouri. Lowering the minimum age of concealed carry to 19 years in Missouri was associated with a 32.0% increase in firearm suicide rates and a 29.7% increase in nonfirearm suicide rates in adolescents aged 14 to 18 years, and a 7.2% increase in firearm suicide rates in young adults aged 19 to 24 years. <h3>Conclusions and Relevance</h3> Increases in rates of suicide by firearms in adolescents and young adults were seen following repeal of Missouri's PTP law and lowering of the minimum age for concealed carry in 2014. Changes in Missouri's firearm policies may be an important contributor to rates of suicide by firearm in young Missouri residents.
Efficacy and Safety of Front-Line Venetoclax and Rituximab (VenR) for the Treatment of Young Patients with Chronic Lymphocytic Leukemia and an Unfavorable Biologic Profile. Preliminary Results of the Gimema Study 'Veritas'
Authors: Francesca Romana Mauro, Gianluigi Reda, Valentina Arena, Livio Trentin, Marta Coscia, Paolo Sportoletti, Luca Laurenti, Gianluca Gaidano, Roberto Marasca, Lorella Orsucci, Roberta Murru, Caterina Stelitano, Fiorella Ilariucci, Donato Mannina, Massimo Massaia, Gian Matteo Rigolin, Lydia Scarfo, Monia Marchetti, Luciano Levato, Monica Tani, Annalisa Arcari, Gerardo Musuraca, Marina Deodato, Piero Galieni, Catello Califano, Daniela Gottardi, Anna Marina Liberati, Daniela Pietrasanta, Stefano Molica, Ramona Cassin, Andrea Visentin, Candida Vitale, Gianfranco Lapietra, Irene Della Starza, Maria Stefania De Propris, Sara Raponi, Mauro Nanni, Ilaria Del Giudice, Giorgia Giuliani, Marco Vignetti, Anna Guarini, Francesco Albano, Antonino Neri, Antonio Cuneo, Robin Foà
Journal: Blood (2020)
Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients
Authors: Amine Belhabri, Liliana Vila, Mael Heiblig, Stephane Morisset, Emmanuelle Nicolas-Virelizier, Clémence Santana, Isabelle Tigaud, Sandrine Hayette, Anne-Sophie Michallet, Philippe Rey, Yann Guillermin, Souad Assad, Laure Lebras, Mauricette Michallet
Journal: Blood (2020)
Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
Authors: Abhay Singh, Matthew Gravina, Rutaba Tajammal, Annmarie Nowak, Renuka Iyer, Mark G. Faber, LunBiao Yan, Duane C. Hassane, Monica L. Guzman, Nuria Mencia-Trinchant, Eunice S. Wang, Swapna Thota
Journal: Blood (2020)
Epidemiology and Outcomes of Hospitalizations Due to Waldenstrom Macroglobulinemia: A National Perspective
Authors: Siddharth Bhesania, Durgesh Agrawal, Sohiel Deshpande, Suchetha Moothat Jagan, Yared Habtewold, Tehrim Zahid, Pritika Manaktala, Janki Bhesania, Alina Barmanwalla, Achint Patel, Neil Nimkar, Sonal Paul, Parag Mehta, Eshan Patel
Journal: Blood (2020)
Next-Generation Sequencing in Non-<i>BCR-ABL</i>Mechanisms Resistance in Patients with Chronic Myeloid Leukemia: Results of a Pilot Study
Authors: Ilya Buldakov, Sergey Voloshin, Mikhail Fominykh, Vasily Shuvaev, Sergey Petrov, Alexander Chechetkin, Irina Martynkevich
Journal: Blood (2020)
A Prospective Economic Analysis of Canadian Cancer Trials Group Clc.2/Alliance A041202: A Randomized Phase III Comparison of Bendamustine-Rituximab Versus Ibrutinib-Based Regimens in Untreated Older Patients with Chronic Lymphocytic Leukemia
Authors: Matthew C. Cheung, Nicole Mittmann, Carolyn Owen, Nizar Abdel-Samad, Graeme Fraser, Selay Lam, Michael Crump, Catherine Sperlich, Richard van der Jagt, Stephen Couban, Jennifer A. Woyach, Amy S. Ruppert, Allison M Booth, Sumithra J Mandrekar, Gail T. McDonald, Lois E. Shepherd, Anca Prica, Hope Yen, Bingshu E. Chen, Annette E. Hay
Journal: Blood (2020)
Endleukemia Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Leukemias in Routine Clinical Care
Authors: Chi Young Ok, Rajesh Singh, Rajyalakshmi Luthra, David Hatfield, Kristen Floyd, Sanam Loghavi, Rashmi Kanagal-Shamanna, Zhuang Zuo, C. Cameron Yin, Mark Routbort, Hagop M. Kantarjian, L. Jeffrey Medeiros, Keyur P. Patel
Journal: Blood (2017)
Machine Learning Methods to Better Predict Post-Hematopoietic Stem Cell Transplant (HSCT) Leukemic Relapse in Pediatric Patients with Acute Lymphoblastic Leukemia: Random Forest (RF) Classification Featuring Serial Post-Transplant Lineage-Specific Chimerism
Authors: David C Shyr, Bing Melody Zhang, Robertson Parkman, Simon E. Brewer
Journal: Blood (2020)
Clinical Value of Next Generation Sequencing in the Detection of Recurring Structural Rearrangements and Copy Number Abnormalities in Acute Myeloid Leukemia
Authors: Beth A Pitel, Neeraj Sharma, Cinthya Zepeda-Mendoza, James B Smadbeck, Kathryn E. Pearce, Stephanie A. Smoley, Joselle Cook, George Vasmatzis, Zohar Sachs, David S. Viswanatha, Robert Jenkins, Xinjie Xu, Sheng Xiao, Nicole Hoppman, Rhett P. Ketterling, Jess Peterson, Patricia Greipp, Linda B Baughn
Journal: Blood (2020)
AML Cells Alter Bone Homeostasis By Promoting the Formation of Immature Bone and Resorption of Mature Bone That Supports Leukemia Progression
Authors: Anudishi Tyagi, Bin Yuan, Stanley Ly, Fouad El-Dana, Vinitha Mary Kuruvilla, Qi Zhang, Christine B Peterson, Xin Zhou, Benoit deCrombrugghe, Michael Andreeff, Marina Konopleva, Behrang Amini, Venkata Lokesh Battula
Journal: Blood (2020)
Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study
Authors: Robert Klamroth, Jerzy Windyga, Vlad Radulescu, Peter W. Collins, Oleksandra Stasyshyn, Hishamshah Mohd Ibrahim, Werner Engl, Srilatha D. Tangada, William Savage, Bruce Ewenstein
Journal: Blood (2020)
MANGANESE NEUROTOXICITY DERIVES IN PART FROM PERTURBED FE/IRE/IRP REGULATION IN RATS AND MODELS OF HUMAN NEURONS
Authors: Vivek Venkataramani, Yanyan Liu, Catherine Cahill, Katharina Fernsebner, Bernhard Michalke, Hong Jiang, Scott Ayton, Ashley Bush, Xudong Huang, Jack Rogers
Journal: American Journal of Hematology (2016)
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast–Driven Nutritional Support and Immunosuppression
Authors: Ralph Francescone, Débora Barbosa Vendramini-Costa, Janusz Franco-Barraza, Jessica Wagner, Alexander Muir, Allison N. Lau, Linara Gabitova, Tatiana Pazina, Sapna Gupta, Tiffany Luong, Dustin Rollins, Ruchi Malik, Roshan J. Thapa, Diana Restifo, Yan Zhou, Kathy Q. Cai, Harvey H. Hensley, Yinfei Tan, Warren D. Kruger, Karthik Devarajan, Siddharth Balachandran, Andres J. Klein-Szanto, Huamin Wang, Wafik S. El-Deiry, Matthew G. Vander Heiden, Suraj Peri, Kerry S. Campbell, Igor Astsaturov, Edna Cukierman
Journal: Cancer Discovery (2020)

Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing in vitro assays, and orthotopic murine models, we identified Netrin G1 (NetG1) as a promoter of PDAC tumorigenesis. We found that NetG1+ cancer-associated fibroblasts (CAF) support PDAC survival, through a NetG1-mediated effect on glutamate/glutamine metabolism. Also, NetG1+ CAFs are intrinsically immunosuppressive and inhibit natural killer cell-mediated killing of tumor cells. These protumor functions are controlled by a signaling circuit downstream of NetG1, which is comprised of AKT/4E-BP1, p38/FRA1, vesicular glutamate transporter 1, and glutamine synthetase. Finally, blocking NetG1 with a neutralizing antibody stunts in vivo tumorigenesis, suggesting NetG1 as potential target in PDAC. SIGNIFICANCE: This study demonstrates the feasibility of targeting a fibroblastic protein, NetG1, which can limit PDAC tumorigenesis in vivo by reverting the protumorigenic properties of CAFs. Moreover, inhibition of metabolic proteins in CAFs altered their immunosuppressive capacity, linking metabolism with immunomodulatory function.See related commentary by Sherman, p. 230.This article is highlighted in the In This Issue feature, p. 211.
Crovalimab for Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Complement C5 Polymorphism - Experience from the Phase I/II COMPOSER Study
Authors: Jun-ichi Nishimura, Kensuke Usuki, Julia Ramos, Satoshi Ichikawa, Jules Hernández-Sánchez, Anna Kiialainen, Alexandre Sostelly, Regis Peffault De Latour, Ido Paz-Priel, Alexander Röth
Journal: Blood (2020)
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma
Authors: Maria Gavriatopoulou, Andriani Boultadaki, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Lia A. Moulopoulos
Journal: Blood (2020)
Hyperbaric Oxygen Therapy for Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation and Effective Factors Prediction
Authors: Yujie Jiang, Hao Chen, Xiaosheng Fang, Xiaohui Sui, Chao Xue, Huiting Qu, Mei Ding, Changqing Zhen, Qian Zhang, Ying Li, Hongzhi Xu, Lingyan Zhang, Xin Wang
Journal: Blood (2020)
Targeting MM at the Nexus between Cell Cycle and Transcriptional Regulation Via CDK7 Inhibition
Authors: Yao Yao, Woojun D Park, Eugenio Morelli, Mehmet Kemal Samur, Nicholas P Kwiatkowski, Yan Xu, Chandraditya Chakraborty, Behnam Nabet, Marta Chesi, Herve Avet-Loiseau, Nathaniel Gray, Richard A. Young, Kenneth Anderson, Charles Y Lin, Nikhil C. Munshi, Mariateresa Fulciniti
Journal: Blood (2020)
Disruption of the m-SWI/SNF Complex Mediated By Recurrent Non-Coding Mutations in BCL7A Induces Tumor Cell Proliferation in Multiple Myeloma
Authors: Chandraditya Chakraborty, Eugenio Morelli, Srikanth Talluri, Sanika Derebail, Yan Xu, Yao Yao, María Linares, Alba Rodríguez García, Kenneth Anderson, Mehmet Kemal Samur, Mariateresa Fulciniti, Nikhil C. Munshi
Journal: Blood (2020)